Proprietary inorganic matrix for dry state room temperature transport and
storage of purified DNA
CARLSBAD, Calif., Oct. 8 /PRNewswire/ -- GenVault Corporation, the leader in dry, room temperature biosample management, announces the launch of an innovative new product, GenTegra(TM) DNA. GenTegra DNA is a proprietary inorganic matrix with built-in oxidative protection and antimicrobial activity for dry, room temperature transport and storage of purified DNA. GenTegra DNA is provided in ready to use aliquots, and purified DNA dried within GenTegra DNA is simply and fully resolubilized with water for direct downstream molecular analysis.
"GenVault's goal is to provide solutions that enable efficiency in biosample management for genomic-based medicine and research. GenTegra DNA is the first of GenVault's next generation of core innovative technologies that will include a broad range of sample types," said David Wellis, Ph.D., CEO of GenVault.
"Our goal at the Eccles Institute of Human Genetics of developing rapid and large-scale genotyping techniques for identifying genetic variations that confer predispositions to human disorders and traits is well served by innovative technologies such as GenTegra(TM) DNA. Preservation of DNA integrity in a dry state room temperature environment such as GenTegra benefits large scale studies and any worldwide genomic community efforts," said Dr. Mark F. Leppert, Ph.D, Professor and Co-Chair, Department of Human Genetics, University of Utah.
"Our work at Scripps Translational Science Institute benefits from
innovative technologies such as GenTegra(TM) for storing and transporting
DNA samples with our collaborators. The genotyping results of frozen
samples and samples stored with GenTegra at room temperature were
identical, indicating that recovered samples were of high purity and
quality," said Sarah Shaw Murray, Ph.D., Director of Genetics, Scripps
Genomic Medicine, The Scripp
|SOURCE GenVault Corporation|
Copyright©2008 PR Newswire.
All rights reserved